← All diseases
Liver, kidneys and digestion
Primary biliary cholangitis
Do you want to receive a message when there is new research about Primary Biliary Cholangitis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll receive a message as soon as there is new research about Primary Biliary Cholangitis. View what Premium costs.
Publications and studies (1840)
- Extracellular matrix protein 1 binds to connective tissue growth factor against liver fibrosis and ductular reaction. (2024/10/30) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Elafibranor (Iqirvo) unveiled: a groundbreaking FDA-approved therapy revolutionizing primary biliary cholangitis treatment. (2024/10/17) ♡
- tdCoxSNN: Time-dependent Cox survival neural network for continuous-time dynamic prediction. (2024/10/11) ♡
- The Varying Histology of Hepatic Sarcoidosis and the Relation of Bile Duct Damage and Loss to the Presence of Portal Hypertension and Cirrhosis. (2024/10/10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN. (2024/10/03) ♡
- Recommendations and quality criteria to improve the early diagnosis of primary biliary cholangitis. (2024/10/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Dietary therapy of murine primary biliary cholangitis induces hepatocellular steatosis: A cautionary tale. (2024/10/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Portal vein hypoplasia is present in patients with biliary atresia at the time of diagnosis. (2024/10/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. eMPower: An online Mind-body wellness Program for adults living with chronic health conditions: A three-armed randomized controlled trial protocol. (2024/10/01) ♡
- Factors associated with progression and outcomes of primary biliary cholangitis: A cohort study, 2010-2019. (2024/09/30) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. The role of 2'-5'-oligoadenylate synthase-like protein (OASL1) in biliary and hepatotoxin-induced liver injury in mice. (2024/09/19) ♡
- Dietary total antioxidant capacity in relation to disease severity and risk of mortality in cirrhosis; results from a cohort study. (2024/09/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive familial intrahepatic cholestasis type 4: a case report. (2024/09/07) ♡
- A home-based exercise programme attenuates fatigue in primary biliary cholangitis: Results from the EXCITED clinical trial. (2024/09/06) ♡
- Validation of a Primary Biliary Cholangitis-Specific Version of Chronic Liver Disease Questionnaire: CLDQ-PBC. (2024/09/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis. (2024/09/01) ♡
- Risk of comorbidity of autoimmune liver disease in patients with inflammatory bowel disease: A single-center case-control study in China. (2024/09/01) ♡
- Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis. (2024/08/31) ♡
- Evaluation of a Ten-Antigen Immunodot Test in Autoimmune Hepatitis and Primary Biliary Cholangitis: Lessons Learned for a Tertiary Care Academic Hospital. (2024/08/28) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comparing body composition measures in children with end stage liver disease using noninvasive bioimpedance analysis. (2024/08/27) ♡
- Circulating Gut Microbe-Derived Metabolites Are Associated with Hepatocellular Carcinoma. (2024/08/26) ♡
- The External Validation of GLOBE and UK-PBC Risk Scores for Predicting Ursodeoxycholic Acid Treatment Response in a Large U.S. Cohort of Primary Biliary Cholangitis Patients. (2024/08/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease. (2024/07/28) ♡
- Loss of β-catenin reveals a role for glutathione in regulating oxidative stress during cholestatic liver disease. (2024/07/05) ♡
- Surrogate markers of bile duct disease progression in primary sclerosing cholangitis - A prospective study with repeated ERCP examinations. (2024/07/02) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis. (2024/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Newer Diagnostic Virological Markers for Hepatitis B Virus Infection. (2024/07/01) ♡
- Perihilar and Intrahepatic Cholangiocarcinoma after Resection: Clinicopathological Characteristics, Outcomes, and Implications for Addition of Chemoradiotherapy. (2024/07/01) ♡
- Regulation of intestinal senescence during cholestatic liver disease modulates barrier function and liver disease progression. (2024/06/29) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Safety of high-carbohydrate fluid diet 2 h versus overnight fasting before non-emergency endoscopic retrograde cholangiopancreatography: A single-blind, multicenter, randomized controlled trial. (2024/06/20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Risk of incident cardiovascular disease among patients with gastrointestinal disorder: a prospective cohort study of 330 751 individuals. (2024/06/20) ♡
- Abdominal Hypoperfusion and Acute Kidney Injury in the Critically Ill Patient with Liver Cirrhosis: A Prospective Cohort Study. (2024/06/18) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort. (2024/06/01) ♡
- Perceived Stigma in Patients with Autoimmune Hepatitis. (2024/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Radiographic and endoscopic findings of checkpoint inhibitor cholangitis. (2024/06/01) ♡
- Undifferentiated HepaRG cells show reduced sensitivity to the toxic effects of M8OI through a combination of CYP3A7-mediated oxidation and a reduced reliance on mitochondrial function. (2024/06/01) ♡
- Good long-term outcomes of primary sclerosing cholangitis in childhood. (2024/05/25) ♡
- Frequency of antithyroid antibodies in patients with primary biliary cholangitis. (2024/05/02) ♡
- Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections-Results from the ICA "Global Study" (EABCIR-Global Study). (2024/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Letter to the Editor: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis. (2024/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reply: Improving access to transient elastography data for real-world prognostic applications in primary biliary cholangitis. (2024/05/01) ♡
- Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States. (2024/05/01) ♡
- Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver. (2024/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm! (2024/05/01) ♡
- Impact of ursodeoxycholic acid therapy in autoimmune liver disease patients with COVID-19 and its clinical prognosis. (2024/04/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autosomal Recessive Polycystic Kidney Disease – PKHD1. (2024/04/04) ♡
- A combined pre- and intra-operative nomogram in evaluation of degrees of liver cirrhosis predicts post-hepatectomy liver failure: a multicenter prospective study. (2024/04/03) ♡
- Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation. (2024/04/01) ♡
- Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort. (2024/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma. (2024/04/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.